Donald Allen Williams insider trades

Open-market stock purchases and sales by Donald Allen Williams, Director at Palisade BIO, Inc, from SEC Form 4 filings since Sep 15, 2014.

Track record: 33% of 6 scored buys are up 5% or more since purchase, averaging +20%.

Recent trades

DateStockTradeValue
Oct 2, 2026PALI Palisade BIO, IncBought$14.6K
Oct 1, 2026PALI Palisade BIO, IncBought$14.2K
Jun 10, 2026PALI Palisade BIO, IncBought (not open market)—
Jun 10, 2026PALI Palisade BIO, IncBought (not open market)—
Jan 16, 2026PALI Palisade BIO, IncBought$8.4K
Jan 9, 2026PALI Palisade BIO, IncBought$9.4K

Companies traded

  • PALI Palisade BIO, Inc: 7 buys, last Oct 2, 2026
  • FBRX Forte Biosciences, Inc: other filings, last Aug 20, 2024
  • ATEC Alphatec Holdings, Inc: 2 buys, last Jun 16, 2021
  • MRNA Marina Biotech, Inc: other filings, last Apr 16, 2018
  • AKTX Akari Therapeutics plc: other filings, last Jun 29, 2016

Get free alerts when Donald Allen Williams files a new trade →